- Home
- MYND vs PASG Comparison
MYND vs PASG Comparison
Compare MYND & PASG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MYND
- PASG
- Stock Information
- Founded
- MYND 1998
- PASG 2017
- Country
- MYND United States
- PASG United States
- Employees
- MYND N/A
- PASG N/A
- Industry
- MYND Other Consumer Services
- PASG Biotechnology: Pharmaceutical Preparations
- Sector
- MYND Real Estate
- PASG Health Care
- Exchange
- MYND Nasdaq
- PASG Nasdaq
- Market Cap
- MYND 38.8M
- PASG 31.1M
- IPO Year
- MYND 2017
- PASG 2020
- Fundamental
- Price
- MYND $0.91
- PASG $0.42
- Analyst Decision
- MYND
- PASG Strong Buy
- Analyst Count
- MYND 0
- PASG 3
- Target Price
- MYND N/A
- PASG $7.67
- AVG Volume (30 Days)
- MYND 16.5K
- PASG 392.9K
- Earning Date
- MYND 06-17-2025
- PASG 05-13-2025
- Dividend Yield
- MYND N/A
- PASG N/A
- EPS Growth
- MYND N/A
- PASG N/A
- EPS
- MYND N/A
- PASG N/A
- Revenue
- MYND $267,380,999.00
- PASG N/A
- Revenue This Year
- MYND N/A
- PASG N/A
- Revenue Next Year
- MYND N/A
- PASG N/A
- P/E Ratio
- MYND N/A
- PASG N/A
- Revenue Growth
- MYND N/A
- PASG N/A
- 52 Week Low
- MYND $0.61
- PASG $0.26
- 52 Week High
- MYND $3.89
- PASG $1.33
- Technical
- Relative Strength Index (RSI)
- MYND 59.58
- PASG 55.85
- Support Level
- MYND $0.83
- PASG $0.40
- Resistance Level
- MYND $0.90
- PASG $0.52
- Average True Range (ATR)
- MYND 0.04
- PASG 0.05
- MACD
- MYND 0.00
- PASG 0.01
- Stochastic Oscillator
- MYND 91.54
- PASG 60.00
About MYND Mynd.ai Inc.
Mynd.ai Inc is a company that provides a platform for delivering digital content in K-12 classrooms, giving teachers seamless connectivity to inspire young minds. It features agnostic hardware that integrates across technology providers. Its product line includes a wide range of interactive tools and technologies, with its award-winning interactive displays at the forefront. It also offers interactive software apps such as Screen Share, computing modules, and accessories that meet the needs of customers, including K -12 educators, colleges and universities, small businesses and corporations, government agencies, and more.
About PASG Passage Bio Inc.
Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease. The Company operates in a single reportable segment, developing and advancing genetic medicines designed to target critical underlying pathology of neurodegenerative diseases.